Testing the safety of SYH2061 in healthy volunteers
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be in generally good health with normal test results or minor issues that the study doctor says are okay.
- You need to have had the meningococcal and pneumococcal vaccines at least 14 days before the first dose, or have proof of them within the last 3 years.
- You must agree to use effective birth control from 14 days before the study starts until 6 months after the last dose.
- You cannot have certain medical conditions, such as immune system problems, recent infections, or recent major surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single dose of an investigational drug called SYH2085 in healthy volunteers to check for side effects, how the body processes the drug, and what happens at different doses. If you qualify, you will help doctors understand if the drug is safe before testing it in patients.
This trial tests an investigational injection called SYH2062 in healthy adults to see if it's safe. It helps researchers understand how the drug affects the body before testing in patients.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This trial tests a new medicine called HS-20152 in healthy people to see if it is safe and how the body handles it. Participants will receive vaccinations before the study to protect against certain infections.
This is an early-stage safety study testing a new experimental tablet called SYH2072 in healthy volunteers. Researchers will give increasing doses to understand how safe it is, how your body processes it, and what effects it has.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
Hear when a new Healthy Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.